Your browser doesn't support javascript.
loading
Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase.
Zhao, Yitian; Zhang, Min; Hou, Xudong; Han, Jiaxin; Qin, Xiaoya; Yang, Yun; Song, Yunqing; Liu, Zhikai; Zhang, Yong; Xu, Zhijian; Jia, Qi; Li, Yiming; Chen, Kaixian; Li, Bo; Zhu, Weiliang; Ge, Guangbo.
  • Zhao Y; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhang M; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Hou X; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Han J; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Qin X; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Yang Y; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Song Y; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Liu Z; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhang Y; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Xu Z; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Jia Q; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Li Y; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Chen K; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Scienc
  • Li B; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: boli@simm.ac.cn.
  • Zhu W; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Scienc
  • Ge G; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: geguangbo@dicp.ac.cn.
Bioorg Med Chem ; 91: 117413, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37490786
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salicilanilidas / Lipasa Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salicilanilidas / Lipasa Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article